Oncotarget

Meta-Analysis:

Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis

Ming-Ming Zhang, Xue-Wei Chang, Xue-Qin Hao, Hao Wang, Xiang Xie and Shou-Yan Zhang _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:9468-9479. https://doi.org/10.18632/oncotarget.23293

Metrics: PDF 1330 views  |   HTML 2023 views  |   ?  


Abstract

Ming-Ming Zhang1,* Xue-Wei Chang1,*, Xue-Qin Hao2, Hao Wang1, Xiang Xie3 and Shou-Yan Zhang1

1Department of Cardiology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, PR China

2Department of Pharmacy, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, PR China

3Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, PR China

*These authors contributed equally to this work

Correspondence to:

Shou-Yan Zhang, email: [email protected]

Xiang Xie, email: [email protected]

Keywords: coronary artery disease; myocardial infarction; matrix metalloproteinase 9; polymorphism; meta-analysis

Received: November 30, 2016     Accepted: December 08, 2017     Published: December 15, 2017

ABSTRACT

Polymorphism (rs3918242) in the MMP9 gene has been reported to be associated with coronary artery disease (CAD). This study aims to investigate a more accurate estimation of the relationship between CAD and rs3918242 polymorphism by a meta-analysis method. We systematically searched studies on the association of rs3918242 polymorphism and CAD in PubMed, Web of Science, the Cochrane Library, Wanfang Data and CNKI. We used Stata 12.0 and RevMan 5.3 software to perform the meta-analyses. A total of 37 case-control studies involving 13,035 CAD patients and 11,372 non-CAD controls were included. A statistically significant association between rs3918242 polymorphism and CAD was observed in allelic model (Odds ratio (OR) 1.34; 95% confidence interval (CI) 1.20–1.50; p < 0.00001), recessive model (OR 1.43; 95% CI 1.17–1.75; p = 0.0004), and in dominant model ( OR 1.36; 95% CI 1.20–1.53; p < 0.00001). Moreover, we also found that there is a statistically significant association between rs3918242 polymorphism and myocardial infarction (MI) in Asians with allelic model (OR 1.66; 95% CI 1.29–2.14; p < 0.0001), recessive model (OR 2.29; 95% CI 1.44–3.63; p = 0.004), and dominant (OR 1.74; 95% CI 1.29–2.35; p = 0.0003) model. A similar result in Caucasians with allelic model (OR 1.14; 95% CI 1.02–1.27; p = 0.02), and in dominant (OR 1.17; 95% CI 1.04–1.32; p = 0.01) model. Our meta-analysis suggested that the MMP9 T allele is a risk factor for CAD and MI.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23293